Bank Of America Corp Singular Genomics Systems, Inc. Transaction History

Bank Of America Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.4 - $0.61 $13 - $20	-34 Reduced 0.32%	10,672 $5,000
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.58 $1,441 - $2,532	-4,367 Reduced 28.97%	10,706 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.28 $32,645 - $53,571	-41,853 Reduced 73.52%	15,073 $12,000
Q1 2023 May 12, 2023	SELL	$1.1 - $2.95 $2,545 - $6,826	-2,314 Reduced 3.91%	56,926 $68,000
Q4 2022 Feb 10, 2023	BUY	$1.82 - $2.71 $44,473 - $66,221	24,436 Added 70.21%	59,240 $119,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $16,430 - $31,085	6,572 Added 23.28%	34,804 $87,000
Q2 2022 Aug 12, 2022	SELL	$2.86 - $6.44 $199,350 - $448,887	-69,703 Reduced 71.17%	28,232 $107,000
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $193,632 - $394,109	32,598 Added 49.89%	97,935 $618,000
Q4 2021 Feb 08, 2022	BUY	$10.45 - $16.9 $636,969 - $1.03 Million	60,954 Added 1390.69%	65,337 $755,000
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $28,688 - $72,722	2,632 Added 150.31%	4,383 $49,000
Q2 2021 Sep 13, 2021	BUY	$23.16 - $31.17 $40,553 - $54,578	1,751 New	1,751 $48,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $948M
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.